Promethera Therapeutics is a Belgian biotechnology company specialized in the treatment of liver disease using cell therapy. It was founded in 2009 by the Technology Transfer Office of the Université Catholique de Louvain and Professor Etienne Sokal, based on the discovery made by the research and clinical team at UCL. Prof Sokal is a leading expert in hepatology and cell therapy.
Promethera® HepaStem is a cell-based therapy for the treatment of both orphan liver-based metabolic diseases and acquired liver diseases. The originality of the therapy is that a wide variety of diseases can be addressed with the same product.
Promethera Therapeutics is now launching its second clinical trial to assess the efficacy of HepaStem in Urea Cycle Disorder patients. The company is currently recruiting patients.
Employees: 51-200
Phone: +32 10 39 43 00
Total raised: $206.63M
Founded date: 2009
Investors 6
| Date | Name | Website |
| - | Mitsui Glo... | mitsui-glo... |
| - | Korea Inve... | partners.k... |
| - | Invest.BW | investbw.b... |
| - | Fund+ | fundplus.b... |
| - | Le Groupe ... | sriw.be |
| - | Beyond Nex... | beyondnext... |
Funding Rounds 7
| Date | Series | Amount | Investors |
| 30.06.2021 | - | $23.75M | - |
| 16.12.2019 | Series D | $52.56M | - |
| 07.05.2019 | Series D | $44.8M | - |
| 10.04.2018 | - | $11.5M | - |
| 28.10.2016 | Series C | $10.99M | - |
| 25.11.2014 | Series C | $31.6M | - |
| 29.03.2012 | Series B | $31.43M | - |
Persons 6
| Date | First Name | Last Name | Title | Location | |||
| - | Joel | Hare | Office Man... | linkedin.c... | - | j*******e@... | - |
| - | Tuba | Baran | R&D Sc... | linkedin.c... | - | t********n... | - |
| - | Etienne | Sokal, MD,... | - | linkedin.c... | - | e*********... | - |
| - | Colin | Mudd | Quality As... | linkedin.c... | - | c********d... | - |
| - | - | - | - | twitter.co... | - | a*********... | - |
| - | Corinne | Audouin | Director I... | linkedin.c... | - | c*********... | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 17.12.2019 | Daily funding roundup - December 17th, 2019 | GrowthPlug raised $1M; Rebank landed $2.8M; Xendoo secured $3.5M; Oto.ai closed $5.3M GrowthPlug: G... | vator.tv/n... |
| 17.12.2019 | Promethera Biosciences, a Belgian startup that works on trea... | Nonalcoholic steatohepatitis (NASH) is the most severe form of non-alcoholic fatty liver disease. It... | siliconcan... |
| 16.12.2019 | Promethera Receives €7.5M Investment; Closes €47.2M Series D... | Promethera Biosciences SA, a Mont-Saint-Guibert, Belgium-based global innovator in cell-based medici... | finsmes.co... |
| 06.12.2019 | Best of 2019: 10 Belgium tech startups that scored maximum f... | Entrepreneurs in Belgium eyeing to raise funds might have an easier time right now to grow their ric... | siliconcan... |
| 07.05.2019 | Promethera Biosciences Completes $44.4M Series D Financing | Promethera Biosciences, a global innovator in cell-based medicines and liver diseases, closed a €39.... | finsmes.co... |
| 07.05.2019 | Belgium's liver-focused stem cell therapy developer ... | Betting on its stem cell therapy for end-stage liver disease, Belgium-based Promethera Biosci... | endpts.com... |
| 07.05.2019 | Daily funding roundup - May 7th, 2019 | Hubtype raised $1.1M; Virtuous closed $3M; MedCrypt landed $5.3M; CollegeDekho secured $8M Aito: Ai... | vator.tv/n... |
| 06.05.2019 | Promethera raises €40M to fund trial of NASH cell therapy | Promethera Biosciences has raised €39.7 million ($44.4 million) to put its liver disease cell therap... | fiercebiot... |
| 06.05.2019 | Promethera raises €40M to fund trial of NASH cell therapy | Promethera Biosciences has raised €39.7 million ($44.4 million) to put its liver disease cell therap... | fiercebiot... |
| 03.08.2018 | Cell Medica scoops Kite Pharma's Chris Nowers as CEO; Shi... | → With several of Cell Medica’s programs on track for clinical trials, Gregg Sando has deci... | endpts.com... |
Show more